PUBLICATION

The antiangiogenic effects of polyisoprenylated cysteinyl amide inhibitors in HUVEC, chick embryo and zebrafish is dependent on the polyisoprenyl moiety

Authors
Nkembo, A.T., Ntantie, E., Salako, O.O., Amissah, F., Poku, R.A., Latinwo, L.M., Lamango, N.S.
ID
ZDB-PUB-160915-2
Date
2016
Source
Oncotarget   7(42): 68194-68205 (Journal)
Registered Authors
Keywords
HUVEC, PCAIs, angiogenesis, cell invasion, zebrafish
MeSH Terms
  • Amides/chemistry
  • Amides/pharmacology*
  • Angiogenesis Inhibitors/pharmacology*
  • Animals
  • Butadienes/chemistry
  • Cell Movement/drug effects
  • Cell Survival/drug effects
  • Cells, Cultured
  • Chick Embryo
  • Chorioallantoic Membrane/blood supply
  • Chorioallantoic Membrane/drug effects*
  • Chorioallantoic Membrane/embryology
  • Embryo, Nonmammalian/blood supply
  • Embryo, Nonmammalian/drug effects*
  • Embryo, Nonmammalian/embryology
  • Hemiterpenes/chemistry
  • Human Umbilical Vein Endothelial Cells/drug effects*
  • Human Umbilical Vein Endothelial Cells/physiology
  • Humans
  • Neovascularization, Physiologic/drug effects*
  • Pentanes/chemistry
  • Polymers/chemistry
  • Zebrafish
PubMed
27626690 Full text @ Oncotarget
Abstract
Angiogenesis is essential for solid tumor growth, therapeutic resistance and metastasis, the latest accounting for 90% of cancer deaths. Although angiogenesis is essential for the malignant transformations in solid tumors and therefore is an attractive target, few drugs are available that block tumor angiogenesis. The focus has been to block signaling by receptor tyrosine kinases (RTKs), such as for vascular endothelial growth factor (VEGF), whose activation abrogate apoptosis and promote angiogenesis. The polyisoprenylated cysteinyl amide inhibitors (PCAIs) were designed to modulate aberrant polyisoprenylated small G-proteins such as mutant Ras whose constitutive activation promotes RTKs signaling. Since polyisoprenylation is essential for protein-protein interactions and functions of G-proteins, we hypothesized that the PCAIs would disrupt the monomeric G-protein signaling thereby effectively inhibiting angiogenesis. In this study we determined the effects of PCAIs on human umbilical vein endothelial cells (HUVEC) tube formation, cell viability, cell migration and invasion as well as in vivo using the chick chorioallantoic membrane (CAM) and zebrafish models. At sub- to low micromolar concentrations, the PCAIs inhibit the native and VEGF-stimulated cell migration and invasion as well as tube formation and angiogenesis in CAM and zebrafish embryos. The concentrations that block the angiogenic processes were lower than those that induce cell death. Since angiogenesis is essential for tumor growth but otherwise limited to wound healing, feeding fat cells and uterine wall repair in adults, it is conceivable that these compounds can be developed into safer therapeutics for cancers and retinal neovascularization that leads to loss of vision.
Genes / Markers
Figures
Show all Figures
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Antibodies
Orthology
Engineered Foreign Genes
Mapping